Group 1 - The company announced a profit forecast indicating a return to losses in 2025, with expected net profit attributable to shareholders ranging from -105 million to -84 million yuan [1] - In 2024, the company reported a total profit of 11.83 million yuan, with a net profit attributable to shareholders of 10.25 million yuan, and a net profit excluding non-recurring gains and losses of -3.28 million yuan [1] - The company is undergoing a strategic adjustment due to changes in industry trends and market conditions, which has led to a decline in revenue and gross profit [1] Group 2 - Since its market debut in July 2021, the company's performance has shown significant volatility, with a 24.69% revenue decline in 2022 and a net profit loss of -124 million yuan [2] - Despite a revenue increase of over 40% in 2023, the company still reported a net profit loss of -50.87 million yuan [2] - The company specializes in the research and development of health products, particularly portable smart massagers, and is recognized as a national high-tech enterprise [3] Group 3 - The company and its actual controller are under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [3] - As of January 28, the company's stock price was 22.23 yuan per share, reflecting a decline of 1.98%, with a total market capitalization of 1.911 billion yuan [3]
倍轻松“不轻松”,预计2025年净利最高亏损过亿,公司及实控人上月底被立案